These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7944330)

  • 21. Positional ordering of reacting groups contributes significantly to the efficiency of proton transfer at an antibody active site.
    Seebeck FP; Hilvert D
    J Am Chem Soc; 2005 Feb; 127(4):1307-12. PubMed ID: 15669871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proceedings of a Conference "Morphogenesis in the individual and historical development", March 16-18, 2011, Moscow, Russia].
    Izv Akad Nauk Ser Biol; 2012; (2):131. PubMed ID: 22787723
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings of the International Symposium on Nonhuman Primate Research in Space, Moscow, Russia, June 22-26, 1998.
    J Gravit Physiol; 2000 Jan; 7(1):S1-172. PubMed ID: 11543435
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of cellular bioenergetics: From molecules to physiology and pathology. Proceedings of the 14th European Bioenergetics Conference. July 22-27, 2006. Moscow, Russia.
    Biochim Biophys Acta; 2006; 1757(5-6):285-726. PubMed ID: 16829223
    [No Abstract]   [Full Text] [Related]  

  • 25. [Engineering antibody: from laboratory to clinic].
    Xiao C; Zhu X
    Sheng Li Ke Xue Jin Zhan; 1997 Oct; 28(4):341-4. PubMed ID: 11038688
    [No Abstract]   [Full Text] [Related]  

  • 26. Natural catalytic antibodies.
    Paul S
    Mol Biotechnol; 1996 Jun; 5(3):197-207. PubMed ID: 8837026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Conference of chief physicians of autonomous republics, territories and regions of the RSFSR (21-June-1968, Moscow)].
    Smetnev AV
    Sov Med; 1969 Jan; 32(1):156-7. PubMed ID: 4247511
    [No Abstract]   [Full Text] [Related]  

  • 28. Tunable Diode Laser Spectroscopy 1998. Proceedings from the 2nd International Conference. Moscow, Russia, 6-10 July 1998.
    Spectrochim Acta A Mol Biomol Spectrosc; 1999 Sep; 55A(10):1919-2144. PubMed ID: 10744448
    [No Abstract]   [Full Text] [Related]  

  • 29. Enzyme Engineering 10. Tenth International Enzyme Engineering Conference, Kashikojima, Japan, September 24-29, 1989. Proceedings.
    Ann N Y Acad Sci; 1990; 613():1-891. PubMed ID: 1981658
    [No Abstract]   [Full Text] [Related]  

  • 30. Display of a functional hetero-oligomeric catalytic antibody on the yeast cell surface.
    Lin Y; Tsumuraya T; Wakabayashi T; Shiraga S; Fujii I; Kondo A; Ueda M
    Appl Microbiol Biotechnol; 2003 Aug; 62(2-3):226-32. PubMed ID: 12883868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Directed evolution of antibody molecules in phage-displayed combinatorial libraries].
    Fujii I
    Yakugaku Zasshi; 2007 Jan; 127(1):91-9. PubMed ID: 17202788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody Engineering--IBC's 17th annual international conference. Antibody engineering and immunotherapeutics for the 21st century.
    Bradbury A
    IDrugs; 2007 Mar; 10(3):169-72. PubMed ID: 17351868
    [No Abstract]   [Full Text] [Related]  

  • 33. Expression studies of catalytic antibodies.
    Ulrich HD; Patten PA; Yang PL; Romesberg FE; Schultz PG
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11907-11. PubMed ID: 8524873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy.
    Rader C; Turner JM; Heine A; Shabat D; Sinha SC; Wilson IA; Lerner RA; Barbas CF
    J Mol Biol; 2003 Sep; 332(4):889-99. PubMed ID: 12972259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactive immunization: a unique approach to catalytic antibodies.
    Tanaka F; Barbas CF
    J Immunol Methods; 2002 Nov; 269(1-2):67-79. PubMed ID: 12379353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings of the 25th Annual Gravitational Physiology Meeting, Moscow, Russia, June 6-11, 2004.
    J Gravit Physiol; 2004 Jul; 11(2):P1-244. PubMed ID: 16229105
    [No Abstract]   [Full Text] [Related]  

  • 37. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Genetic Constructs for Generation of Stable Therapeutic Antibodies to Organophosphorus Toxins in Methylotrophic Yeasts Pichia Pastoris.
    Mokrushina YA; Stepanova AV; Bobik TV; Smirnov IV; Gabibov AG
    Bull Exp Biol Med; 2016 May; 161(1):83-7. PubMed ID: 27270933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective chemotherapeutic strategies using catalytic antibodies: a common pro-moiety for antibody-directed abzyme prodrug therapy.
    Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):269-81. PubMed ID: 12379367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catalytic antibodies and their applications in biotechnology: state of the art.
    Padiolleau-Lefèvre S; Ben Naya R; Shahsavarian MA; Friboulet A; Avalle B
    Biotechnol Lett; 2014 Jul; 36(7):1369-79. PubMed ID: 24652545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.